Author:
Gossas Thomas,Vrang Lotta,Henderson Ian,Sedig Susanne,Sahlberg Christer,Lindström Erik,Danielson U. Helena
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology,General Medicine
Reference29 articles.
1. Andersen K, Weinberger MH, Egan B, Constance CM, Ali MA, Jin J, Keefe DL (2008) Comparative efficacy and safety of aliskiren, an oral direct renin inhibitor, and ramipril in hypertension: a 6-month, randomized, double-blind trial. J Hypertens 26:589–599
2. Baldwin JJ, Claremon DA, Tice C, Cacatian S, Dillard LW, Ishchenko AV, Yuan J, Xu Z, McGeehan G, Zhao W, Simpson RD, Singh SB, Flaherty PT, Wery J-P (2006) WO2006/042150, Apr. 20, 2006; CAN 144:432692.
3. Biswas KB, Nabi AH, Arai Y, Nakagawa T, Ebihara A, Ichihara A, Watanabe T, Inagami T, Suzuki F (2010) Aliskiren binds to renin and prorenin bound to (pro)renin receptor in vitro. Hypertens Res 33:1053–1059
4. Carilli CT, Vigne JL, Wallace LC, Smith LM, Wong MA, Lewicki JA, Baxter JD (1988) Characterization of recombinant human prorenin and renin. Hypertension 11:713–716
5. Copeland RA, Pompliano DL, Meek TD (2006) Drug-target residence time and its implications for lead optimization. Nat Rev Drug Discov 5:730–739
Cited by
6 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献